Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 6
1982 5
1983 2
1984 4
1985 5
1986 10
1987 8
1988 12
1989 11
1990 13
1991 11
1992 16
1993 11
1994 7
1995 16
1996 11
1997 15
1998 14
1999 15
2000 14
2001 26
2002 26
2003 55
2004 52
2005 71
2006 55
2007 73
2008 89
2009 93
2010 79
2011 120
2012 135
2013 158
2014 203
2015 189
2016 202
2017 229
2018 236
2019 278
2020 338
2021 447
2022 477
2023 495
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

3,898 results

Results by year

Filters applied: . Clear all
Page 1
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: gu sz. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: gu s. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
Sahu A, Wang X, Munson P, Klomp JPG, Wang X, Gu SS, Han Y, Qian G, Nicol P, Zeng Z, Wang C, Tokheim C, Zhang W, Fu J, Wang J, Nair NU, Rens JAP, Bourajjaj M, Jansen B, Leenders I, Lemmers J, Musters M, van Zanten S, van Zelst L, Worthington J, Liu JS, Juric D, Meyer CA, Oubrie A, Liu XS, Fisher DE, Flaherty KT. Sahu A, et al. Among authors: gu ss. Cancer Discov. 2023 Mar 1;13(3):672-701. doi: 10.1158/2159-8290.CD-22-0244. Cancer Discov. 2023. PMID: 36745048 Free PMC article.
Neuroendocrine pathogenesis of perimenopausal depression.
Han Y, Gu S, Li Y, Qian X, Wang F, Huang JH. Han Y, et al. Among authors: gu s. Front Psychiatry. 2023 Mar 30;14:1162501. doi: 10.3389/fpsyt.2023.1162501. eCollection 2023. Front Psychiatry. 2023. PMID: 37065890 Free PMC article. Review.
Povidone-iodine enhanced underwater tape.
Song Z, Gu S, Tang T, Wu J. Song Z, et al. Among authors: gu s. J Mater Chem B. 2022 Dec 7;10(47):9906-9913. doi: 10.1039/d2tb02115c. J Mater Chem B. 2022. PMID: 36448473
Artificial Intelligence in Oncological Hybrid Imaging.
Feuerecker B, Heimer MM, Geyer T, Fabritius MP, Gu S, Schachtner B, Beyer L, Ricke J, Gatidis S, Ingrisch M, Cyran CC. Feuerecker B, et al. Among authors: gu s. Nuklearmedizin. 2023 Oct;62(5):296-305. doi: 10.1055/a-2157-6810. Epub 2023 Oct 6. Nuklearmedizin. 2023. PMID: 37802057 Review. English.
People-inspired names remain valuable.
Antonelli A, Farooq H, Colli-Silva M, Araújo JPM, Freitas AVL, Gardner EM, Grace O, Gu S, Marline L, Nesbitt M, Niskanen T, Onana JM, Pérez-Escobar OA, Taylor C, Knapp S. Antonelli A, et al. Among authors: gu s. Nat Ecol Evol. 2023 Aug;7(8):1161-1162. doi: 10.1038/s41559-023-02108-7. Nat Ecol Evol. 2023. PMID: 37337005 No abstract available.
Emerging roles of epigenetics in lead-induced neurotoxicity.
Mei Z, Liu G, Zhao B, He Z, Gu S. Mei Z, et al. Among authors: gu s. Environ Int. 2023 Nov;181:108253. doi: 10.1016/j.envint.2023.108253. Epub 2023 Oct 13. Environ Int. 2023. PMID: 37864902 Free article. Review.
Murine Models and Research Progress on Dysmenorrhea.
Tuo L, Tang S, Li S, Gu S, Xie Z. Tuo L, et al. Among authors: gu s. Reprod Sci. 2023 Aug;30(8):2362-2372. doi: 10.1007/s43032-023-01220-0. Epub 2023 Apr 3. Reprod Sci. 2023. PMID: 37010703 Review.
3,898 results